top of page

Navigate to: A ... H ... O ... Z

Curated from the NCI drug list with >100 malignant hem, onc, and supportive care drugs of relevance added by my personal review of major guidelines such as NCCN, ASH, etc.. 

FDA approved Malig. Hem / Onc drugs through Jan. 2024  I  Next Update 5/2024  I  Benign Hem. Drugs in process

Your content has been submitted

An error occurred. Try again later

Generic Drug Name
Brand Name
Drug Classification
Abatacept
Orencia
Immunosuppressant, T-cell Costimulation Inhibitor
Abemaciclib
Verzenio
Small Molecule Kinase Inhibitors, Cyclin-Dependent Kinase Inhibitors
Abiraterone Acetate
Zytiga; Yonsa
Hormonal Therapies, Androgens and Anti-Androgens
Acalabrutinib
Calquence
Small Molecule Kinase Inhibitors, Bruton's Tyrosine Kinase (BTK) Inhibitors
Acitretin
Soriatane
Vitamin A derivative (retinoid)
Adagrasib
Krazati
Small Molecule GTPase Inhibitors, Kirsten rat sarcoma virus (KRAS)
Ado-Trastuzumab Emtansine (T-Dm1)
Kadcyla
Antibody-Drug Conjugate
Afatinib
Gilotrif
Small Molecule Kinase Inhibitors, Epidermal Growth Factor Receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) (oral) Inhibitors
Aldesleukin (Interleukin-2)
Proleukin
Recombinant Proteins, Hormones, and Enzymes
Alectinib Hydrochloride
Alecensa
Small Molecule Kinase Inhibitors, Anaplastic Lymphoma Kinase (ALK), Mesenchymal Epithelial Transition (MET) Growth Factor Inhibitors, Rearranged During Transfection (RET), Proto-Oncogene Ros1 (ROS1), and Neurotrophic Tyrosine Receptor Kinase (NTRK) Inhibitors
Alemtuzumab
Campath
Monoclonal Antibodies, Immune Checkpoint Inhibitors
Alitretinoin
Panretin
Vitamin A derivative (retinoid)
Alpelisib
Piqray, Vijoice
Small Molecule Kinase Inhibitors, Phosphoinositide-3 Kinase (Pi3K) Inhibitors
Amifostine
Ethyol
Antidote to Chemotherapy Toxicity
Amivantamab-vmjw
Rybrevant
Monoclonal Antibodies
Anakinra
Kineret
Monoclonal Antibodies
Anastrozole
Arimidex
Hormonal Therapies, Aromatase Inhibitors
Andexanet Alfa
Andexxa
other
Antithymocyte Globulin Equine
Atgam
other
Antithymocyte Globulin Rabbit
Thymoglobulin
other
Apalutamide
Erleada
Hormonal Therapies, Androgens and Anti-Androgens
Apixaban
Elliquis
anticoagulant
Aprepitant
Emend (Fosaprepitant Also Branded As Emend)
Antiemetic
Arsenic Trioxide
Trisenox
Arsenicals
Asciminib
Scemblix
Small Molecule Kinase Inhibitors, BCR-ABL1 Inhibitors
Atezolizumab
Tecentriq
Monoclonal Antibodies, Immune Checkpoint Inhibitors
Avapritinib
Ayvakit
Small Molecule Kinase Inhibitors, Kit (CD117), Platelet Derived Growth Factor Receptor Alpha (PDGFRA), and Colony Stimulating Factor 1 Receptor (CSFR1)
Avatrombopag Maleate
Doptelet
Small Molecule TPO Receptor agonists
Avelumab
Bavencio
Monoclonal Antibodies, Immune Checkpoint Inhibitors
Axicabtagene Ciloleucel (Axi-Cel)
Yescarta
Immune Effector Cell Therapy
Axitinib
Inlyta
Small Molecule Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR)/Multi-Targeted Inhibitors
Azacitidine
Onureg; Vidaza
Epigenetic Regulation Modifiers
Bcg (Bacillus Calmette-Guerin)
Tice
Antineoplastic agent, other
Belantamab Mafodotin-blmf
Blenrep
Antibody-Drug Conjugate
Belinostat
Beleodaq
Epigenetic Regulation Modifiers
Belumosudil
Rezurock
Small Molecule Kinase Inhibitors, Other
Belzutifan
Welireg
small molecule targeted therapy
Bendamustine Hydrochloride
Treanda
Cytotoxic Chemotherapy, Alkylating
Betibeglogene Autotemcel
Zynteglo
Gene Therapy
Bevacizumab
Avastin; Alymsys; Zirabev
Monoclonal Antibodies
Bevacizumab-Awwb
Mvasi
Monoclonal Antibodies
Bexarotene
Targretin
Vitamin A derivative (retinoid)
Bicalutamide
Bicalutamide
Hormonal Therapies, Androgens and Anti-Androgens
Binimetinib
Mektovi
Small Molecule Kinase Inhibitors, Mitogen-Activated Protein Kinase (MEK) Inhibitors
Bleomycin
Blenoxane
Antineoplastic agent, other
Blinatumomab
Blincyto
Bispecific T Cell Engager
Bortezomib
Velcade
Proteasome Inhibitors
Bosutinib Monohydrate
Bosulif
Small Molecule Kinase Inhibitors, BCR-ABL1 Inhibitors
Brentuximab Vedotin
Adcetris
Antibody-Drug Conjugate
Brexucabtagene Autoleucel (Brexu-Cel)
Tecartus
Immune Effector Cell Therapy
Brigatinib
Alunbrig
Small Molecule Kinase Inhibitors, Anaplastic Lymphoma Kinase (ALK), Mesenchymal Epithelial Transition (MET) Growth Factor Inhibitors, Rearranged During Transfection (RET), Proto-Oncogene Ros1 (ROS1), and Neurotrophic Tyrosine Receptor Kinase (NTRK) Inhibitors
Buprenorphine
Subutex
Opioid Receptor Agonists and Antagonists
Bupropion Hydrochloride
Zyban
Dopamine/Norepinephrine Reuptake Inhibitor; Smoking Cessation Aid
Busulfan
Busulfex, Myleran
Cytotoxic Chemotherapy, Alkylating
Butalbital, Acetaminophen, Caffeine, And Codeine Phosphate
Fioricet With Codeine
Opioid Agonists and Antagonists
Cabazitaxel
Jevtana
Cytotoxic Chemotherapy, Anti-Tubulin Agents
Cabozantinib
Cabometyx
Small Molecule Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR)/Multi-Targeted Inhibitors
Cabozantinib
Cometriq
Small Molecule Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR)/Multi-Targeted Inhibitors
Calaspargase Pegol
Asparlas
Antineoplastic agent, other
Capecitabine
Xeloda
Cytotoxic Chemotherapy, Antimetabolites
Capivasertib
Truqap
Small Molecule Kinase Inhibitors, Other
Caplacizumab
Cablivi
Monoclonal Antibodies
Capmatinib
Tabrecta
Small Molecule Kinase Inhibitors, Other
Carboplatin
Paraplatin
Cytotoxic Chemotherapy, Alkylating
Carfilzomib
Kyprolis
Proteasome Inhibitors
Carmustine
Bcnu
Cytotoxic Chemotherapy, Alkylating
Carmustine Implant
Gliadel Wafer
Cytotoxic Chemotherapy, Alkylating
Cemiplimab-Rwlc
Libtayo
Monoclonal Antibodies, Immune Checkpoint Inhibitors
Ceritinib
Zykadia
Small Molecule Kinase Inhibitors, Anaplastic Lymphoma Kinase (ALK), Mesenchymal Epithelial Transition (MET) Growth Factor Inhibitors, Rearranged During Transfection (RET), Proto-Oncogene Ros1 (ROS1), and Neurotrophic Tyrosine Receptor Kinase (NTRK) Inhibitors
Cetuximab
Erbitux
Monoclonal Antibodies
Chlorambucil
Leukeran
Cytotoxic Chemotherapy, Alkylating
Ciltacabtagene Autoleucel (Cilta-Cel)
Carvykti
Immune Effector Cell Therapy
Cisplatin
Cisplatin
Cytotoxic Chemotherapy, Alkylating
Citalopram Hydrobromide
Celexa
Selective Serotonin Reuptake Inhibitor (SSRI)
Cladribine
Cladribine
Cytotoxic Chemotherapy, Antimetabolites
Clofarabine
Clofarabine
Cytotoxic Chemotherapy, Antimetabolites
Cobimetinib
Cotellic
Small Molecule Kinase Inhibitors, Mitogen-Activated Protein Kinase (MEK) Inhibitors
Copanlisib
Aliqopa
Small Molecule Kinase Inhibitors, Phosphoinositide-3 Kinase (Pi3K) Inhibitors
Crizanlizumab
Akadveo
Sickle Cell Disease Therapeutics, not otherwise specified
Crizotinib
Xalkori
Small Molecule Kinase Inhibitors, Anaplastic Lymphoma Kinase (ALK), Mesenchymal Epithelial Transition (MET) Growth Factor Inhibitors, Rearranged During Transfection (RET), Proto-Oncogene Ros1 (ROS1), and Neurotrophic Tyrosine Receptor Kinase (NTRK) Inhibitors
Cyclophosphamide
Cytoxan
Cytotoxic Chemotherapy, Alkylating
Cyclosporine
Neoral
Immunosuppressant, Calcineurin Inhibitor
Cytarabine
Cytarabine
Cytotoxic Chemotherapy, Antimetabolites
Dabigatran Etexilate Mesylate
Pradaxa
anticoagulant
Dabrafenib
Tafinlar
Small Molecule Kinase Inhibitors, B-Raf (BRAF) Inhibitors
Dacarbazine
Dacarbazine
Cytotoxic Chemotherapy, Alkylating
Dacomitinib
Vizimpro
Small Molecule Kinase Inhibitors, Epidermal Growth Factor Receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) (oral) Inhibitors
Dactinomycin
Dactinomycin
Cytotoxic Chemotherapy, DNA-Damaging Agents
Dalteparin Sodium
Fragmin
anticoagulant
Daratumumab (Intravenous)
Darzalex
Monoclonal Antibodies
Daratumumab And Hyaluronidase-Fihj (Subcutaneous)
Darzalex Faspro
Monoclonal Antibodies
Darbepoetin Alfa
Aranesp
Recombinant Proteins, Hormones, and Enzymes
Darolutamide
Nubeqa
Hormonal Therapies, Androgens and Anti-Androgens
Dasatinib
Sprycel
Small Molecule Kinase Inhibitors, BCR-ABL1 Inhibitors
Daunorubicin Hydrochloride
Rubidomycin
Cytotoxic Chemotherapy, Anthracyclines, Topoisomerase II inhibitor
Decitabine
Decitabine
Epigenetic Regulation Modifiers
Decitabine And Cedazuridine
Inquovi
Epigenetic Regulation Modifiers
Degarelix
Firmagon
Hormonal Therapies, Gonadotropin-Releasing Hormone Analogues
Denileukin Diftitox
Ontak
Recombinant Proteins, Hormones, and Enzymes
Denosumab
Prolia; Xgeva
Bone Metabolism Modifiers: bisphosphonates and RANKL inhibitors
Dexamethasone
Decadron
Corticosteroids
Dexrazoxane Hydrochloride
Totect; Zinecard
Antidote to Chemotherapy Toxicity
Dinutuximab
Unituxin
Monoclonal Antibodies
Docetaxel Anhydrous
Taxotere
Cytotoxic Chemotherapy, Anti-Tubulin Agents
Dostarlimab-Gxly
Jemperli
Monoclonal Antibodies, Immune Checkpoint Inhibitors
Doxorubicin Hydrochloride
Adriamycin
Cytotoxic Chemotherapy, Anthracyclines, Topoisomerase II inhibitor
Duloxetine Hydrochloride
Cymbalta
Serotonin and Norepinephrine Reuptake Inhibitor (SNRI)
Durvalumab
Imfinzi
Monoclonal Antibodies, Immune Checkpoint Inhibitors
Duvelisib
Copiktra
Small Molecule Kinase Inhibitors, Phosphoinositide-3 Kinase (Pi3K) Inhibitors
Eculizumab
Soliris
Monoclonal Antibodies
Edoxaban Tosylate
Savaysa
anticoagulant
Elacestrant
Orserdu
Hormonal Therapies, Estrogens and Selective Estrogen Response Modifiers
Elotuzumab
Empliciti
Monoclonal Antibodies
Eltrombopag Olamine
Promacta
Small Molecule TPO Receptor agonists
Emapalumab
Gamifant
Monoclonal Antibodies
Enasidenib Mesylate
Idhifa
Small Molecule Kinase Inhibitors, Other
Encorafenib
Braftovi
Small Molecule Kinase Inhibitors, B-Raf (BRAF) Inhibitors
Enfortumab Vedotin-ejfv
Padcev
Antibody-Drug Conjugate
Enoxaparin Sodium
Enoxaparin Sodium
anticoagulant
Entrectinib
Rozlytrek
Small Molecule Kinase Inhibitors, Anaplastic Lymphoma Kinase (ALK), Mesenchymal Epithelial Transition (MET) Growth Factor Inhibitors, Rearranged During Transfection (RET), Proto-Oncogene Ros1 (ROS1), and Neurotrophic Tyrosine Receptor Kinase (NTRK) Inhibitors
Enzalutamide
Xtandi
Hormonal Therapies, Androgens and Anti-Androgens
Epirubicin Hydrochloride
Ellence
Cytotoxic Chemotherapy, Anthracyclines, Topoisomerase II inhibitor
Epoetin Alfa
Procrit; Retacrit
Recombinant Proteins, Hormones, and Enzymes
Epoetin Alfa
Epogen
Recombinant Proteins, Hormones, and Enzymes
Erdafitinib
Balversa
Small Molecule Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR)/Multi-Targeted Inhibitors
Eribulin Mesylate
Halaven
Cytotoxic Chemotherapy, Anti-Tubulin Agents
Erlotinib Hydrochloride
Tarceva
Small Molecule Kinase Inhibitors, Epidermal Growth Factor Receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) (oral) Inhibitors
Erwinia Asparaginase
Erwinaze
Antineoplastic agent, other
Erwinia Asparaginase (Recombinant)
Rylaze
Antineoplastic agent, other
Escitalopram Oxalate
Lexapro
Selective Serotonin Reuptake Inhibitor (SSRI)
Etoposide
Etopophos
Cytotoxic Chemotherapy, Topoisomerase II Inhibitors
Etranacogene Dezaparvovec-Drlb
Hemgenix
Gene Therapy
Everolimus
Everolimus
Immunosuppresant, mTOR inhibitors
Everolimus
Afinitor
Small Molecule Kinase Inhibitors, Mammalian Target Of Rapamycin (MTOR) Inhibitors
Exagamglogene Autotemcel
Casgevy
Gene Therapy
Exemestane
Aromasin
Hormonal Therapies, Aromatase Inhibitors
Fam-Trastuzumab Deruxtecan-Nxki (T-Dxd)
Enhertu
Antibody-Drug Conjugate
Fedratinib Hydrochloride
Inrebic
Small Molecule Kinase Inhibitors, Janus Kinase (Jak) Inhibitors and FMS-like tyrosine kinase 3 (FLT3) inhibitors
Fentanyl Transdermal System
Duragesic
Opioid Receptor Agonists and Antagonists
Filgrastim
Neupogen; Granix; Nivestym; Zarxio
Recombinant Proteins, Hormones, and Enzymes
Filgrastim
Releuko
Recombinant Proteins, Hormones, and Enzymes
Fludarabine Phosphate
Fludarabine Phosphate
Cytotoxic Chemotherapy, Antimetabolites
Fluorouracil
Fluorouracil
Cytotoxic Chemotherapy, Antimetabolites
Fluorouracil (Topical)
Tolak
Cytotoxic Chemotherapy, Antimetabolites
Fluoxetine Hydrochloride
Prozac
Selective Serotonin Reuptake Inhibitor (SSRI)
Flutamide
Eulexin
Hormonal Therapies, Androgens and Anti-Androgens
Fondaparinux Sodium
Fondaparinux Sodium
anticoagulant
Fosaprepitant
Emend (Aprepitant Also Branded As Emend)
Antiemetic
Fostamatinib Disodium
Tavalisse
Small Molecule Kinase Inhibitors, Other
Fulvestrant
Fulvestrant
Hormonal Therapies, Estrogens and Selective Estrogen Response Modifiers
Futibatinib
Lytgobi
Small Molecule Kinase Inhibitors, Other
Gabapentin
Neurontin
other
Gefitinib
Iressa
Small Molecule Kinase Inhibitors, Epidermal Growth Factor Receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) (oral) Inhibitors
Gemcitabine Hydrochloride
Gemzar; Infugem
Cytotoxic Chemotherapy, Antimetabolites
Gemtuzumab Ozogamicin
Mylotarg
Antibody-Drug Conjugate
Gilteritinib
Xospata
Small Molecule Kinase Inhibitors, Janus Kinase (Jak) Inhibitors and FMS-like tyrosine kinase 3 (FLT3) inhibitors
Glasdegib
Daurismo
small molecule targeted therapy
Glofitamab-Gxbm
Columvi
Bispecific T Cell Engager
Glucarpidase
Voraxaze
Antidote to Chemotherapy Toxicity
Goserelin
Zoladex
Hormonal Therapies, Gonadotropin-Releasing Hormone Analogues
Granisetron Hydrochloride
Kytril; Sancuso
Antiemetic

Anchor 2
Generic Drug Name
Brand Name
Drug Classification
Heparin Sodium
Heparin Sodium
anticoagulant
Hydrocortisone
Solu-Cortef
Corticosteroids
Hydromorphone Hydrochloride
Dilaudid
Opioid Receptor Agonists and Antagonists
Hydroxyurea
Hydrea
Sickle Cell Disease Therapeutics, not otherwise specified
Ibritumomab Tiuxetan (With In-111 And Y-90)
Zevalin
Radioactive Therapeutic and Diagnostic Agents
Ibrutinib
Imbruvica
Small Molecule Kinase Inhibitors, Bruton's Tyrosine Kinase (BTK) Inhibitors
Idarubicin Hydrochloride
Idamycin Pfs
Cytotoxic Chemotherapy, Anthracyclines, Topoisomerase II inhibitor
Idarucizumab
Praxbind
other
Idecabtagene Vicleucel (Ide-Cel)
Abecma
Immune Effector Cell Therapy
Idelalisib
Zydelig
Small Molecule Kinase Inhibitors, Phosphoinositide-3 Kinase (Pi3K) Inhibitors
Ifosfamide
Ifex
Cytotoxic Chemotherapy, Alkylating
Imatinib Mesylate
Gleevec
Small Molecule Kinase Inhibitors, BCR-ABL1 Inhibitors
Imiquimod
Aldara; Zyclara
other
Infigratinib Phosphate
Truseltiq
Small Molecule Kinase Inhibitors, Other
Inotuzumab Ozogamicin
Besponsa
Antibody-Drug Conjugate
Interferon-Gamma-1B
Actimmune
Recombinant Proteins, Hormones, and Enzymes
Iobenguane I 131
Azedra
Radioactive Therapeutic and Diagnostic Agents
Ipilimumab
Yervoy
Monoclonal Antibodies, Immune Checkpoint Inhibitors
Irinotecan Hydrochloride
Irinotecan Hydrochloride 100 Mg/5 Ml
Cytotoxic Chemotherapy, Topoisomerase I Inhibitors
Isatuximab-Irfc
Sarclisa
Monoclonal Antibodies
Ivosidenib
Tibsovo
Small Molecule Targeted Therapy, Isocitrate Dehydrogenase (IDH) Inhibitors
Ixabepilone
Ixempra
Cytotoxic Chemotherapy, Anti-Tubulin Agents
Ixazomib
Ninlaro
Proteasome Inhibitors
L - Glutamine
Endari
Sickle Cell Disease Therapeutics, not otherwise specified
Lanreotide Acetate
Somatuline Depot
Recombinant Proteins, Hormones, and Enzymes
Lapatinib
Tykerb
Small Molecule Kinase Inhibitors, Epidermal Growth Factor Receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) (oral) Inhibitors
Larotrectinib
Vitrakvi
Small Molecule Kinase Inhibitors, Anaplastic Lymphoma Kinase (ALK), Mesenchymal Epithelial Transition (MET) Growth Factor Inhibitors, Rearranged During Transfection (RET), Proto-Oncogene Ros1 (ROS1), and Neurotrophic Tyrosine Receptor Kinase (NTRK) Inhibitors
Lenalidomide
Revlimid
Immunomodulatory Drugs (IMiDs)
Lenvatinib
Lenvima
Small Molecule Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR)/Multi-Targeted Inhibitors
Letrozole
Letrozole
Hormonal Therapies, Aromatase Inhibitors
Letrozole And Ribociclib
Kisqali Femara Co-Pack
Small Molecule Kinase Inhibitors, Cyclin-Dependent Kinase Inhibitors
Leucovorin Calcium
Fusilev
other
Leuprolide Acetate
Eligard; Lupron Depot
Hormonal Therapies, Gonadotropin-Releasing Hormone Analogues
Leuprolide Mesylate
Camcevi
Hormonal Therapies, Gonadotropin-Releasing Hormone Analogues
Levonorgestrel And Ethinyl Estradiol
Iclevia
Hormonal Therapies, Contraceptives
Liposomal Daunorubicin And Cytarabine
Vyxeos
other
Liposomal Doxorubicin
Doxil
Cytotoxic Chemotherapy, Anthracyclines, Topoisomerase II inhibitor
Liposomal Irinotecan
Onivyde
Cytotoxic Chemotherapy, Topoisomerase I Inhibitors
Lisocabtagene Maraleucel (Liso-Cel)
Breyanzi
Immune Effector Cell Therapy
Lomustine
Gleostine
Cytotoxic Chemotherapy, Alkylating
Loncastuximab Tesirine-lpyl
Zynlonta
Antibody-Drug Conjugate
Lorlatinib
Lorbrena
Small Molecule Kinase Inhibitors, Anaplastic Lymphoma Kinase (ALK), Mesenchymal Epithelial Transition (MET) Growth Factor Inhibitors, Rearranged During Transfection (RET), Proto-Oncogene Ros1 (ROS1), and Neurotrophic Tyrosine Receptor Kinase (NTRK) Inhibitors
Lovotibeglogene Autotemcel
Lyfgenia
Gene Therapy
Lurbinectedin
Zepzelca
Cytotoxic Chemotherapy, Alkylating
Luspatercept-Aamt
Reblozyl
Recombinant Proteins, Hormones, and Enzymes
Lusutrombopag
Mulpleta
Small Molecule TPO Receptor agonists
Lutetium Lu 177 Dotatate
Lutathera
Radioactive Therapeutic and Diagnostic Agents
Lutetium Lu 177 Vipivotide Tetraxetan
Pluvicto
Radioactive Therapeutic and Diagnostic Agents
Margetuximab-Cmkb
Margenza
Monoclonal Antibodies
Mechlorethamine Hydrochloride
Valchlor
Cytotoxic Chemotherapy, Alkylating
Medroxyprogesterone Acetate
Medroxyprogesterone Acetate
Hormonal Therapies, Contraceptives
Megestrol Acetate
Megestrol Acetate
Hormonal Therapies, Progestins and Antiprogestins
Melphalan Hydrochloride
Evomela; Alkeran; Hepzato
Cytotoxic Chemotherapy, Alkylating
Mercaptopurine
Purinethol; Purixan
Cytotoxic Chemotherapy, Antimetabolites
Mesna
Mesnex
Antidote to Chemotherapy Toxicity
Methadone Hydrochloride
Dolophine
Opioid Receptor Agonists and Antagonists
Methotrexate
Trexall; Xatmep
Cytotoxic Chemotherapy, Antimetabolites
Methylnaltrexone Bromide
Relistor
Opioid Agonists and Antagonists
Methylphenidate Hydrochloride
Ritalin
CNS Stimulant
Midostaurin
Rydapt
Small Molecule Kinase Inhibitors, Janus Kinase (Jak) Inhibitors and FMS-like tyrosine kinase 3 (FLT3) inhibitors
Mirtazapine
Remeron
Alpha-2-Antagonist; Appetite Stimulant
Mirvetuximab Soravtansine-gynx
Elahere
Antibody-Drug Conjugate
Mitomycin
Jelmyto
Cytotoxic Chemotherapy, Alkylating
Mitotane
Lysodren
other
Mitoxantrone
Mitoxantrone
Cytotoxic Chemotherapy, Anthracyclines, Topoisomerase II inhibitor
Mogamulizumab-Kpkc
Poteligeo
Monoclonal Antibodies
Momelotinib Dihydrochloride Monohydrate
Ojjaara
Small Molecule Kinase Inhibitors, Janus Kinase (Jak) Inhibitors and FMS-like tyrosine kinase 3 (FLT3) inhibitors
Morphine Sulfate
Morphine Sulfate
Opioid Receptor Agonists and Antagonists
Mosunetuzumab-Axgb
Lunsumio
Bispecific T Cell Engager
Moxetumomab Pasudotox-tdfk
Lumoxiti
Antibody-Drug Conjugate
Mycophenylate Mofetil
Cellcept
Immunosuppressant
Nadofaragene Firaden
Adstiladrin
Gene Therapy
Nadofaragene Firadenovec-Vncg
Adstiladrin
Gene Therapy
Naxitamab-Gqgk
Danyelza
Monoclonal Antibodies
Necitumumab
Portrazza
Monoclonal Antibodies
Nelarabine
Arranon
Cytotoxic Chemotherapy, Antimetabolites
Neratinib
Nerlynx
Small Molecule Kinase Inhibitors, Epidermal Growth Factor Receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) (oral) Inhibitors
Netupitant And Palonosetron Hydrochloride
Akynzeo
Antiemetic
Nilotinib
Tasigna
Small Molecule Kinase Inhibitors, BCR-ABL1 Inhibitors
Nilutamide
Nilandron
Hormonal Therapies, Androgens and Anti-Androgens
Niraparib
Zejula
Poly(ADP-ribose) polymerase (PARP) inhibitors
Niraparib And Abiraterone
Akeega
Poly(ADP-ribose) polymerase (PARP) inhibitors
Nirogacestat Hydrobromide
Ogsiveo
small molecule targeted therapy
Nivolumab
Opdivo
Monoclonal Antibodies, Immune Checkpoint Inhibitors
Nivolumab And Relatlimab-Rmbw
Opdualag
Monoclonal Antibodies, Immune Checkpoint Inhibitors

H

Anchor 1

O

Z

Generic Drug Name
Brand Name
Drug Classification
Obinutuzumab
Gazyva
Monoclonal Antibodies
Octreotide Acetate
Sandostatin
Recombinant Proteins, Hormones, and Enzymes
Ofatumumab
Kesimpta; Arzerra
Monoclonal Antibodies
Olaparib
Lynparza
Poly(ADP-ribose) polymerase (PARP) inhibitors
Olutasidenib
Rezlidhia
Small Molecule Targeted Therapy, Isocitrate Dehydrogenase (IDH) Inhibitors
Omacetaxine Mepesuccinate
Synribo
Small Molecule Kinase Inhibitors, BCR-ABL1 Inhibitors
Omidubicel-Only
Omisirge
Gene Therapy
Ondansetron Hydrochloride
Zofran
Antiemetic
Osimertinib
Tagrisso
Small Molecule Kinase Inhibitors, Epidermal Growth Factor Receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) (oral) Inhibitors
Oxaliplatin
Oxaliplatin
Cytotoxic Chemotherapy, Alkylating
Oxycodone Hydrochloride
Oxecta
Opioid Receptor Agonists and Antagonists
Paclitaxel (Albumin-Bound)
Paclitaxel Protein-Bound Particles For Injectable Suspension (Albumin-Bound)
Cytotoxic Chemotherapy, Anti-Tubulin Agents
Pacritinib
Vonjo
Small Molecule Kinase Inhibitors, Janus Kinase (Jak) Inhibitors and FMS-like tyrosine kinase 3 (FLT3) inhibitors
Palbociclib
Ibrance
Small Molecule Kinase Inhibitors, Cyclin-Dependent Kinase Inhibitors
Palifermin
Kepivance
Recombinant Proteins, Hormones, and Enzymes
Palonosetron Hydrochloride
Aloxi
Antiemetic
Pamidronate Disodium
Aredia
Bone Metabolism Modifiers: bisphosphonates and RANKL inhibitors
Panitumumab
Vectibix
Monoclonal Antibodies
Paroxetine Hydrochloride Hemihydrate
Paxil
Selective Serotonin Reuptake Inhibitor (SSRI)
Pazopanib Hydrochloride
Votrient
Small Molecule Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR)/Multi-Targeted Inhibitors
Pegaspargase
Oncaspar
Antineoplastic agent, other
Pegaspargase
Oncaspar
Recombinant Proteins, Hormones, and Enzymes
Pegfilgrastim
Neulasta; Nyvepria; Undencyca; Ziextenzo
Recombinant Proteins, Hormones, and Enzymes
Peginterferon Alfa-2A
Pegasys
Recombinant Proteins, Hormones, and Enzymes
Pembrolizumab
Keytruda
Monoclonal Antibodies, Immune Checkpoint Inhibitors
Pemetrexed Disodium
Alimta; Pemfexy
Cytotoxic Chemotherapy, Antimetabolites
Pemigatinib
Pemazyre
Small Molecule Kinase Inhibitors, Other
Pentostatin
Pentostatin
Cytotoxic Chemotherapy, Antimetabolites
Pertuzumab
Perjeta
Monoclonal Antibodies
Pertuzumab And Trastuzumab And Hyaluronidase-zzxf
Phesgo
Antibody-Drug Conjugate
Pexidartinib
Turalio
Small Molecule Kinase Inhibitors, Other
Pirtobrutinib
Jaypirca
Small Molecule Kinase Inhibitors, Bruton's Tyrosine Kinase (BTK) Inhibitors
Plerixafor
Mozobil
other
Polatuzumab Vedotin-piiq
Polivy
Antibody-Drug Conjugate
Pomalidomide
Pomalyst
Immunomodulatory Drugs (IMiDs)
Ponatinib Hydrochloride
Iclusig
Small Molecule Kinase Inhibitors, BCR-ABL1 Inhibitors
Pralatrexate
Folotyn
Cytotoxic Chemotherapy, Antimetabolites
Pralsetinib
Gavreto
Small Molecule Kinase Inhibitors, Other
Prednisone
Prednisone
Corticosteroids
Pregabalin
Lyrica
other
Procarbazine Hydrochloride
Matulane
Cytotoxic Chemotherapy, Alkylating
Prochlorperazine Maleate
Compazine
Antiemetic
Promethazine Hydrochloride
Phenergan
Antiemetic
Propranolol Hydrochloride
Hemangeol
other
Quizartinib Dihydrochloride
Vanflyta
Small Molecule Kinase Inhibitors, Janus Kinase (Jak) Inhibitors and FMS-like tyrosine kinase 3 (FLT3) inhibitors
Radium 223 Dichloride
Xofigo
Radioactive Therapeutic and Diagnostic Agents
Raloxifene Hydrochloride
Evista
Hormonal Therapies, Estrogens and Selective Estrogen Response Modifiers
Ramucirumab
Cyramza
Monoclonal Antibodies
Rasburicase
Elitek
Recombinant Proteins, Hormones, and Enzymes
Ravulizumab
Ultomiris
Monoclonal Antibodies
Regorafenib
Stivarga
Small Molecule Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR)/Multi-Targeted Inhibitors
Relugolix
Orgovyx
Hormonal Therapies, Gonadotropin-Releasing Hormone Analogues
Repotrectinib
Augtyro
Small Molecule Kinase Inhibitors, Anaplastic Lymphoma Kinase (ALK), Mesenchymal Epithelial Transition (MET) Growth Factor Inhibitors, Rearranged During Transfection (RET), Proto-Oncogene Ros1 (ROS1), and Neurotrophic Tyrosine Receptor Kinase (NTRK) Inhibitors
Retifanlimab-Dlwr
Zynyz
Monoclonal Antibodies, Immune Checkpoint Inhibitors
Ribociclib
Kisqali
Small Molecule Kinase Inhibitors, Cyclin-Dependent Kinase Inhibitors
Ripretinib
Qinlock
Small Molecule Kinase Inhibitors, Kit (CD117), Platelet Derived Growth Factor Receptor Alpha (PDGFRA), and Colony Stimulating Factor 1 Receptor (CSFR1)
Rituximab
Rituxan; Riabni; Ruxience; Truxima
Monoclonal Antibodies
Rituximab And Hyaluronidase
Rituxan Hycela
Monoclonal Antibodies
Rivaroxaban
Xarelto
anticoagulant
Rolapitant
Varubi
Antiemetic
Romidepsin
Istodax
Epigenetic Regulation Modifiers
Romiplostim
Nplate
Recombinant Proteins, Hormones, and Enzymes
Ropeginterferon Alfa-2B-Njft
Besremi; Intron A
Recombinant Proteins, Hormones, and Enzymes
Rucaparib
Rubraca
Poly(ADP-ribose) polymerase (PARP) inhibitors
Ruxolitinib
Jakifi
Small Molecule Kinase Inhibitors, Janus Kinase (Jak) Inhibitors and FMS-like tyrosine kinase 3 (FLT3) inhibitors
Sacituzumab Govitecan-hziy
Trodelvy
Antibody-Drug Conjugate
Selinexor
Xpovio
other
Selpercatinib
Retevmo
Small Molecule Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR)/Multi-Targeted Inhibitors
Selumetinib
Koselugo
Small Molecule Kinase Inhibitors, Mitogen-Activated Protein Kinase (MEK) Inhibitors
Sertraline Hydrochloride
Zoloft
Selective Serotonin Reuptake Inhibitor (SSRI)
Siltuximab
Sylvant
Monoclonal Antibodies
Sipuleucel-T
Provenge
Immune Effector Cell Therapy
Sirolimus
Fyarro
Small Molecule Kinase Inhibitors, Mammalian Target Of Rapamycin (MTOR) Inhibitors
Sirolimus
Rapamune
Small Molecule Kinase Inhibitors, Mammalian Target Of Rapamycin (MTOR) Inhibitors
Sonidegib
Odomzo
small molecule targeted therapy
Sorafenib
Nexavar
Small Molecule Kinase Inhibitors, Other
Sotorasib
Lumakras
Small Molecule GTPase Inhibitors, Kirsten rat sarcoma virus (KRAS)
Streptozocin
Zanosar
Cytotoxic Chemotherapy, Alkylating
Sunitinib Malate
Sutent
Small Molecule Kinase Inhibitors, Kit (CD117), Platelet Derived Growth Factor Receptor Alpha (PDGFRA), and Colony Stimulating Factor 1 Receptor (CSFR1)
Tacrolimus (Alias: Fk506)
Prograf
Immunosuppressant, Calcineurin Inhibitor
Tafasitamab-Cxix
Monjuvi
Monoclonal Antibodies
Tagraxofusp-erzs
Elzonris
Antibody-Drug Conjugate
Talazoparib
Talzenna
Poly(ADP-ribose) polymerase (PARP) inhibitors
Talimogene Laherparepvec
Imlygic
Tumor vaccines and viral-based immunotherapeutics
Talimogene Laherparepvec
Imlygic
Gene Therapy
Talquetamab-Tgvs
Talvey
Bispecific T Cell Engager
Tamoxifen Citrate
Soltamox
Hormonal Therapies, Estrogens and Selective Estrogen Response Modifiers
Tazarotene (Cream)
Tazorac
Vitamin A derivative (retinoid)
Tazemetostat
Tazverik
Epigenetic Regulation Modifiers
Tebentafusp-Tebn
Kimmtrak
Bispecific T Cell Engager
Teclistamab-Cqyv
Tecvayli
Bispecific T Cell Engager
Temozolomide
Temodar
Cytotoxic Chemotherapy, Alkylating
Temsirolimus
Torisel
Small Molecule Kinase Inhibitors, Mammalian Target Of Rapamycin (MTOR) Inhibitors
Tepotinib Hydrochloride
Tepmetko
Small Molecule Kinase Inhibitors, Other
Thalidomide
Thalomid
Immunomodulatory Drugs (IMiDs)
Thioguanine
Tabloid
Cytotoxic Chemotherapy, Antimetabolites
Thiotepa
Tepadina
Cytotoxic Chemotherapy, Alkylating
Tisagenlecleucel (Tisa-Cel)
Kymriah
Immune Effector Cell Therapy
Tisotumab Vedotintftv
Tivdak
Antibody-Drug Conjugate
Tivozanib
Fotivda
Small Molecule Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR)/Multi-Targeted Inhibitors
Tocilizumab
Actemra
Monoclonal Antibodies
Topotecan
Hycamtin
Cytotoxic Chemotherapy, Topoisomerase I Inhibitors
Toremifene
Fareston
Hormonal Therapies, Estrogens and Selective Estrogen Response Modifiers
Toripalimab-Tpzi
Loqtorzi
Monoclonal Antibodies, Immune Checkpoint Inhibitors
Trabectedin
Yondelis
Cytotoxic Chemotherapy, Alkylating
Tramadol Hydrochloride
Ultram
Opioid Receptor Agonists and Antagonists
Trametinib
Mekinist
Small Molecule Kinase Inhibitors, Mitogen-Activated Protein Kinase (MEK) Inhibitors
Trastuzumab
Herceptin; Herzuma; Kanjinti; Ogivri; Ontruzant; Trazimera
Monoclonal Antibodies
Trastuzumab And Hyaluronidase-Oysk
Herceptin Hylecta
Monoclonal Antibodies
Trazodone Hydrochloride
Trazodone Hydrochloride
Serotonin Reuptake Inhibitor/Antagonist
Tremelimumab-Actl
Imjudo
Monoclonal Antibodies, Immune Checkpoint Inhibitors
Tretinoin (Atra)
Vesanoid
Vitamin A derivative (retinoid)
Trifluridine And Tipiracil
Lonsurf
Cytotoxic Chemotherapy, Antimetabolites
Triptorelin Pamoate
Trelstar
Hormonal Therapies, Gonadotropin-Releasing Hormone Analogues
Tucatinib
Tukysa
Small Molecule Kinase Inhibitors, Epidermal Growth Factor Receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) (oral) Inhibitors
Uridine Triacetate
Vistogard
Antidote to Chemotherapy Toxicity
Valoctocogene Roxaparvovec-Rvox
Roctavian
Gene Therapy
Valrubicin Intravesical Solution
Valstar
Cytotoxic Chemotherapy, Anthracyclines, Topoisomerase II inhibitor
Vandetanib
Caprelsa
Small Molecule Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR)/Multi-Targeted Inhibitors
Varenicline
Chantix
Smoking Cessation Aid
Vemurafenib
Zelboraf
Small Molecule Kinase Inhibitors, B-Raf (BRAF) Inhibitors
Venetoclax
Venclexta
BCL-2 (B-cell lymphoma-2) inhibitor
Venlafaxine
Effexor Xr
Serotonin and Norepinephrine Reuptake Inhibitor (SNRI)
Vinblastine Sulfate
Vinblastine Sulfate
Cytotoxic Chemotherapy, Anti-Tubulin Agents
Vincristine Sulfate
Vincristine Sulfate
Cytotoxic Chemotherapy, Anti-Tubulin Agents
Vinorelbine
Navelbine
Cytotoxic Chemotherapy, Anti-Tubulin Agents
Vismodegib
Erivedge
small molecule targeted therapy
Vorinostat
Zolinza
Epigenetic Regulation Modifiers
Voxelotor
Oxybryta
Sickle Cell Disease Therapeutics, not otherwise specified
Warfarin Sodium
Warfarin Sodium
anticoagulant
Zanubrutinib
Brukinsa
Small Molecule Kinase Inhibitors, Bruton's Tyrosine Kinase (BTK) Inhibitors
Ziv-Aflibercept
Zaltrap
Recombinant Proteins, Hormones, and Enzymes
Zoledronic Acid
Zometa
Bone Metabolism Modifiers: bisphosphonates and RANKL inhibitors
Anchor 3
Anchor 4
bottom of page